The Group's principal activity is to provide clinical diagnosis. The Group offers 'in vitro' diagnosis which serves as the basis for medical diagnosis, patient treatment and therapy monitoring. The Group contributes to the field of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory infection and pathologies such as cancer and cardiovascular diseases. The Group performs clinical diagnosis through three technologies, bacteriology, immunoassays and molecular biology. The industrial applications include the analysis of the industrial sample like food, pharmaceutical and cosmetic products. The environment sample of water, air and surface determines the microbiological quality. The Group operates in Europe, North America, Asia-Pacific and Latin America.
Alacra Alerts:
Receive alerts on the latest reports on Biomerieux S.A.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
